HEM Pharma Inc. Logo

HEM Pharma Inc.

Develops microbiome-based healthcare solutions, products, and CDMO services.

376270 | KO

Overview

Corporate Details

ISIN(s):
KR7376270005
LEI:
Country:
South Korea
Address:
경기도 수원시 영통구 창룡대로256번길 50 711호, 수원시

Description

HEM Pharma Inc. is a biotechnology company specializing in microbiome-based healthcare solutions. The company researches and develops Live Biotherapeutic Products (LBPs), health functional foods, and other bio-products derived from human-effective microbes. A core component of its R&D is the proprietary Pharmaceutical Meta-Analysis System (PMAS), a technology platform that simulates the human gut microbiome to screen for and analyze beneficial microorganisms. In addition to its product pipeline, HEM Pharma provides personalized healthcare services based on microbiome analysis and offers Contract Development and Manufacturing Organization (CDMO) services for next-generation biological materials.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-26 00:00
반기보고서 (2025.06)
Korean 1.5 MB
2025-06-26 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-06-18 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-21 00:00
분기보고서 (2025.03)
Korean 1.4 MB
2025-05-08 00:00
임시주주총회결과
Korean 4.9 KB
2025-04-23 00:00
주주총회소집공고
Korean 62.3 KB
2025-04-03 00:00
기업설명회(IR)개최
Korean 6.8 KB
2025-03-31 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.5 KB
2025-03-31 00:00
주식매수선택권부여에관한신고
Korean 16.2 KB
2025-03-31 00:00
본점소재지변경
Korean 5.3 KB
2025-03-31 00:00
주주총회소집결의
Korean 6.2 KB
2025-03-31 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-03-31 00:00
정기주주총회결과
Korean 31.0 KB
2025-03-31 00:00
[기재정정]신규시설투자등
Korean 12.1 KB
2025-03-21 00:00
감사보고서제출
Korean 19.1 KB

Automate Your Workflow. Get a real-time feed of all HEM Pharma Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HEM Pharma Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HEM Pharma Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.